Caspofungin Acetate
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2605 publications
Harnessing random peptide mixtures to combat multidrug-resistant fungal infections.
Journal: mBio
Published: April 14, 2026
Successful Outcome of Rhino-Orbital-Cerebral Mucormycosis With Extensive Intracranial Disease in a Patient With Poorly Controlled Diabetes.
Journal: The Permanente journal
Published: March 23, 2026
Comment on 'Retrospective analysis of pharmacological therapeutic monitoring of caspofungin in patients undergoing continuous renal replacement therapy using polyacrylonitrile membranes'.
Journal: The Journal of antimicrobial chemotherapy
Published: March 19, 2026
Synergistic activity of caspofungin and posaconazole against Candida (Candidozyma) auris biofilms based on phenotypic, transcriptomic, and in vivo insights.
Journal: Microbiology spectrum
Published: March 12, 2026
Retrospective analysis of pharmacological therapeutic monitoring of caspofungin in patients undergoing continuous renal replacement therapy using polyacrylonitrile membranes-right to reply.
Journal: The Journal of antimicrobial chemotherapy
Published: March 11, 2026
Quiescence improves Candida albicans survival of fungicidal drug exposure.
Journal: bioRxiv : the preprint server for biology
Published: March 11, 2026
Breakthrough Invasive Fungal Infections in Pediatric Acute Myeloid and Lymphoblastic Leukemia Receiving Mold-active Prophylaxis.
Journal: The Pediatric infectious disease journal
Published: March 03, 2026
Exploring Early Antifungal Activity of Rezafungin as a Stepping-Stone for Shorter Treatment Duration for Candidemia: Pooled Analysis of 2 Randomized Trials.
Journal: Open forum infectious diseases
Published: February 24, 2026
Fungal prophylaxis and prevalence of fungal infections in children with cancer.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: February 24, 2026
The novel second-generation triterpenoid SCY-247 maintains in vitro and in vivo activity against resistant Candida glabrata.
Journal: Antimicrobial agents and chemotherapy
Published: February 19, 2026
Mitochondrial cardiolipin sequestration of caspofungin underlies Cryptococcus neoformans inherent resistance and may contribute to cardiotoxicity.
Journal: bioRxiv : the preprint server for biology
Published: February 06, 2026
Last Updated: 04/28/2026